Contact UsInvestorsCareersMediaScienceContact Us

Latest News 

Media Centre l Our Voice

How Pfizer's Global Efforts Are Helping Protect Children from Pneumonia


In recognition of National Child Day, Pfizer Canada is proud to highlight the organization's global efforts to help protect children from pneumonia, the leading infectious cause of mortality in children under five years old...

Digital Health Week 2024: Exploring the Future of Canada’s Digital Health with Pfizer’s First Healthcare Hub Winners


To celebrate Digital Health Week, Pfizer connected with our Healthcare Hub’s first round of homegrown Canadian innovators to discuss their vision for the future of digital health. 

World Pneumonia Day: Supporting Vaccination Efforts Across Canada


This World Pneumonia Day, we highlight the importance of vaccination and the crucial role of awareness in boosting vaccine uptake. As we mark World Pneumonia Day, we reflect on this significant health issue as pneumonia is one of the leading causes of hospitalization in Canada. Pneumococcus is the most common cause of community acquired bacterial pneumonia and can be serious.

Empowering Early Breast Cancer Detection through Innovation


Every day in Canada, someone’s life is forever changed by a breast cancer diagnosis.  However, access to care, particularly early detection, varies drastically depending on where you live. This Breast Cancer Awareness Month, we explore the current state of breast cancer diagnosis in Canada and highlight how technology can help address barriers to care and push the envelope on early detection.

Meet Jacquie Baker, Recipient of the CCS-Pfizer ATTR-CM 2023 Research Fellowship Award

Jacquie Baker, PhD, is a postdoctoral fellow in the Department of Cardiac Sciences at the Cumming School of Medicine, University of Calgary. She is also the recipient of the CCS-Pfizer ATTR-CM 2023 Research Fellowship Award. We sat down with Jacquie to learn more about her project and how she is hoping to advance care for amyloidosis patients.

An Van Gerven Is Appointed President of Pfizer Canada

An Van Gerven has been named President of Pfizer Canada ULC. An will be succeeding Najah Sampson, who held the position since May 2022 and has been appointed to lead Pfizer’s Hospital business in the United States.  

Pfizer Canada and the Skin Spectrum Summit Announce 2024 Recipients of the Canadian Skin of Colour & Diversity Scholarship

Today, Pfizer Canada ULC and the Skin Spectrum Summit are pleased to announce the winners of the 2024 Canadian Skin of Colour & Diversity Scholarship program which aims to improve dermatological care for underrepresented populations, including those with deeper skin tones, Indigenous Peoples, and other racialized individuals.

Culturally Responsive Health Care: Wellness Wheel Clinical Team and their Approach to Care with First Nations Communities

Wellness Wheel Medical Clinic is a not-for-profit organization dedicated to providing equitable access to high quality clinical and holistic care for Indigenous and vulnerable populations.

Caring for Aging Parents with Compassion and Wisdom

As our parents and loved ones grow older, many of us find ourselves taking on new caregiving responsibilities. This can be a challenging transition, both emotionally and practically. However, there are ways to navigate this process and ensure our older relatives receive the support they need.

Pfizer’s Commitment to Indigenous Health Research

In collaboration with the Canadian Cardiovascular Society and the Canadian Heart Function Alliance, Pfizer is proud to fund research awards that seek to empower Indigenous communities and close gaps in health outcomes between Indigenous and non-Indigenous communities.

Celebrating World Pharmacist Day: How PharmaGuide Empowers Pharmacists to Help Enhance Patient Care in Canada

In celebration of World Pharmacist Day, Pfizer connected with PharmaGuide’s CEO Walid Mowaswes and COO Faddy Morgan, whose Richmond Hill, Ontario-based startup uses artificial intelligence to streamline drug coverage processes.

Pfizer Canada and BioNTech Receive Health Canada Approval of Omicron KP.2 Variant Adapted COVID-19 Vaccine

Omicron KP.2 variant adapted vaccine COMIRNATY® is now authorized in Canada for individuals 6 months of age and older. It is expected to be available in Canada in the coming weeks.

The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage.

Embracing the Power of Science. Striving to Cure and Prevent Human Disease. 

Pfizer Canada ULC is the Canadian operation of Pfizer Inc., one of the world's leading biopharmaceutical companies. At Pfizer, we apply science and our global resources to bring therapies to people that help extend and improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products. Every day, Pfizer colleagues work to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time.

  • About Us

  • Therapeutic Areas

  • PfizerPro for Professionals

  • Community Support

  • Our Work with Patient Groups

Pfizer Canada Healthcare Hub

As part of Pfizer Canada’s ongoing commitment to transform lives through the power of purpose-driven innovation, the Pfizer Canada Healthcare Hub brings together the best and brightest of Canada’s tech industry to champion better patient care. 

Learn More

Careers

Are you looking for a unique career that positively impacts the health and well-being of Canadians at every stage of life?

Apply Today!

Contact Us

Do you have questions about our products or have a general enquiry about the organization? 

Contact Info
About UsOur ProductsHelping Communities Our Voice Suppliers Distribution ChannelPfizer WorldwideMedia CentreTerms Of Use Careers Healthcare ProfessionalsContact UsPrivacy PolicyCopyright © Pfizer Canada 2022 All rights reserved. The information is intended only for residents of Canada. ® Pfizer Inc, used under license